Live Analyst Rating Changes 16810 upgrades, downgrades & price-target moves · freshest Wall Street data, updated daily View live feed →
Analyst Tracker/Scott Henry
AG

Scott Henry

Alliance Global Partners
Wall Street Analyst
★★★☆☆
#1470
on 13Foresight · ranked by our own returns
37%
Success Rate
+10.5%
Average Return
13 of 35 calls profitable · -0.1% vs benchmark
S&P 500 (SPY)
📈 Across the calls we could measure, roughly 37% of Scott Henry's ratings turned a profit when each position was held for 1 year — averaging +10.5% per rating. These figures are computed by 13Foresight from historical prices, not supplied by the analyst.

Rating Distribution

41 Buy 3 Hold 0 Sell
Scott's Stock Coverage 54 ratings · 2026-08-02
Company Date Position Consensus ⓘ Price Target ⓘ 1-Yr Return vs S&P 500 ⓘ
MDCX
Medicus Pharma Ltd
 Jul 28, 2026 BUY Strong Buy
+4176.6% avg upside
5 analysts
$1.00
263.33% Upside
 -1.8% ·
VVOS
Vivos Therapeutics
 Jul 08, 2026 HOLD Strong Buy
+4479.3% avg upside
4 analysts
$0.75
82.93% Upside
 -15.4% ·
NNOX
Nano-X Imaging
 Jul 07, 2026 HOLD Strong Buy
+844.0% avg upside
7 analysts
$3.00
206.22% Upside
 -22.2% ·
MDWD
Mediwound
 May 28, 2026 BUY Strong Buy
+53.0% avg upside
13 analysts
$22.00
55.79% Upside
 -4.4% ·
EVGN
Evogene
 May 26, 2026 BUY Strong Buy
+2205.4% avg upside
6 analysts
$2.15
356.40% Upside
 -31.0% ·
IRIX
Iridex
 May 20, 2026 BUY Strong Buy
+459.0% avg upside
3 analysts
$2.75
235.46% Upside
 -17.0% ·
FBIO
Fortress Biotech
 May 18, 2026 BUY Buy
+152.4% avg upside
12 analysts
$5.00
59.71% Upside
 +25.4% ·
RNXT
RenovoRx
 May 15, 2026 BUY Strong Buy
+567.8% avg upside
5 analysts
$3.00
212.96% Upside
 +9.5% ·
DERM
Journey Medical Corp
 May 14, 2026 BUY Strong Buy
+93.6% avg upside
11 analysts
$16.00
151.26% Upside
 -0.9% ·
PTN
Palatin Technologies
 May 14, 2026 BUY Strong Buy
+1421.7% avg upside
4 analysts
$47.50
516.95% Upside
 -47.7% ·
TNON
Tenon Medical, Inc.
 May 13, 2026 BUY Strong Buy
+4824.3% avg upside
3 analysts
$2.25
1036.44% Upside
 -72.5% ·
ICCM
Icecure Medical
 May 13, 2026 BUY Strong Buy
+1363.0% avg upside
5 analysts
$30.00
938.12% Upside
 -59.4% ·
MYO
Myomo
 May 11, 2026 BUY Strong Buy
+622.7% avg upside
9 analysts
$3.00
197.03% Upside
 +17.6% ·
LPCN
Lipocine
 May 11, 2026 BUY Strong Buy
+749.0% avg upside
4 analysts
$6.00
182.99% Upside
 -8.2% ·
QSI
Quantum-Si
 May 08, 2026 BUY Buy
+250.9% avg upside
3 analysts
$2.50
250.87% Upside
 -20.6% ·
SRTS
Sensus Healthcare
 May 08, 2026 BUY Buy
+132.0% avg upside
8 analysts
$6.50
123.41% Upside
 -6.2% ·
MTNB
Matinas BioPharma
 Nov 01, 2024 HOLD Buy
+4614.1% avg upside
7 analysts
 — +137.1% ·
TSE:MDP
Medexus Pharmaceuticals Inc
 Dec 01, 2023 BUY Strong Buy
+10.1% avg upside
5 analysts
$4.21
16.14% Downside
 +89.7% ·
DYNTQ
Dynatronics
 Nov 09, 2023 BUY Buy
+393333233.4% avg upside
4 analysts
$4.00
399999900.04% Upside
 · ·
RVPH
Reviva Pharmaceuticals Holdings
 Oct 30, 2023 BUY Strong Buy
+9911.1% avg upside
9 analysts
$12.00
2640.61% Upside
 · ·
CSBR
Champions Oncology
 Sep 22, 2023 BUY Strong Buy
+58.6% avg upside
6 analysts
$7.50
39.89% Upside
 -11.7% ·
DCTH
Delcath Systems
 Aug 16, 2023 BUY Strong Buy
+75.9% avg upside
11 analysts
$13.00
6.46% Upside
 +38.6% ·
LMAT
Lemaitre Vascular
 Aug 09, 2023 HOLD Buy
+0.7% avg upside
15 analysts
$58.00
42.76% Downside
 +48.2% ·
IRMD
Iradimed
 Aug 07, 2023 BUY Strong Buy
-7.9% avg upside
6 analysts
$55.00
39.43% Downside
 -12.6% ·
XAIR
Beyond Air
 Jun 28, 2023 BUY Strong Buy
+1641.3% avg upside
10 analysts
$12.00
127.56% Upside
 · ·
LGND
Ligand Pharma
 May 05, 2023 BUY Strong Buy
-8.5% avg upside
15 analysts
$97.00
66.25% Downside
 -6.8% ·
VKTX
Viking Therapeutics
 May 03, 2023 BUY Strong Buy
+127.4% avg upside
31 analysts
$24.00
24.40% Downside
 +258.8% ·
IONM
Assure Holdings
 Apr 12, 2023 BUY Strong Buy
+1599900.1% avg upside
2 analysts
$12.00
2399900.05% Upside
 · ·
IVF
INVO Fertility
 Jun 07, 2022 HOLD Strong Buy
+878.4% avg upside
3 analysts
$1.50
60.03% Upside
 · ·
INM
InMed Pharmaceuticals
 May 16, 2022 HOLD Hold
+1260.5% avg upside
3 analysts
$20.00
1260.45% Upside
 · ·
RDHL
RedHill Biopharma
 Mar 19, 2021 BUY Strong Buy
+2976.9% avg upside
7 analysts
$12.00
1746.23% Upside
 · ·
BNGO
BioNano Genomics
 Dec 04, 2020 HOLD Strong Buy
+784.5% avg upside
9 analysts
$0.75
29.85% Downside
 · ·
STEX
Streamex
 Mar 30, 2020 BUY Strong Buy
+1220.6% avg upside
5 analysts
$9.00
1167.88% Upside
 · ·
HYPD
Hyperion DeFi
 Dec 04, 2019 BUY Strong Buy
+217.1% avg upside
8 analysts
$12.00
354.49% Upside
 · ·
ZVRA
Zevra Therapeutics
 Nov 15, 2019 HOLD Strong Buy
+136.4% avg upside
15 analysts
$0.90
90.52% Downside
 +13.2% ·
INDP
Indaptus Therapeutics
 Nov 14, 2019 HOLD Strong Buy
+7089.9% avg upside
6 analysts
$17.00
1217.90% Upside
 · ·
DXR
Daxor
 Sep 30, 2019 HOLD Strong Buy
+106.4% avg upside
6 analysts
$18.00
71.44% Upside
 +63.7% ·
TNXP
Tonix Pharma
 Aug 30, 2019 BUY Strong Buy
+176.4% avg upside
8 analysts
$13.00
29.79% Upside
 · ·
HIND
Vyome Holdings
 Feb 26, 2019 HOLD Strong Buy
+1389.4% avg upside
8 analysts
$27.50
1200.23% Upside
 · ·
SDEV
Stablecoin Development Corp
 Nov 16, 2018 HOLD Buy
+12.2% avg upside
7 analysts
$2.00
73.92% Upside
 · ·
BTTC
Black Titan
 May 18, 2018 HOLD Hold
+1210.1% avg upside
2 analysts
$9.00
1210.10% Upside
 · ·
AIXC
AIxCrypto Holdings
 Mar 19, 2018 BUY Strong Buy
+1562.1% avg upside
7 analysts
$18.00
2619.84% Upside
 · ·
ANIP
ANI Pharmaceuticals
 Nov 02, 2017 HOLD Strong Buy
+30.0% avg upside
11 analysts
$64.00
19.16% Downside
 -12.9% ·
NL:PHARM
Pharming Group
 Oct 27, 2017 BUY Strong Buy
+275.7% avg upside
4 analysts
 — +11.9% ·
FATE
Fate Therapeutics
 Apr 06, 2017 BUY Strong Buy
+391.1% avg upside
31 analysts
$8.00
226.49% Upside
 +121.0% ·
CANF
Can-Fite BioPharma
 Mar 01, 2017 BUY Strong Buy
+62.4% avg upside
8 analysts
$4.00
27.00% Upside
 · ·
SEELQ
Seelos Therapeutics
 Jan 19, 2017 HOLD Buy
+46385614.3% avg upside
10 analysts
$2.70
2699900.03% Upside
 · ·
ACAD
ACADIA Pharmaceuticals
 Jan 19, 2017 HOLD Strong Buy
+40.1% avg upside
43 analysts
$25.00
3.43% Downside
 -14.3% ·
TLOG
Tetralogic Pharma
 Dec 31, 2015 BUY Strong Buy
+10833233.4% avg upside
3 analysts
$5.00
12499900.08% Upside
 · ·
CORBF
Global Cord Blood
 Nov 25, 2015 HOLD Strong Buy
+785.0% avg upside
3 analysts
$7.25
662.30% Upside
 -21.0% ·
CRMD
Cormedix
 Nov 16, 2015 HOLD Strong Buy
+98.7% avg upside
13 analysts
$2.50
66.73% Downside
 -30.8% ·
IDXG
Interpace Diagnostics Group
 Aug 24, 2015 BUY Strong Buy
+688.4% avg upside
9 analysts
$3.00
97.77% Upside
 · ·
WINT
Windtree Therapeutics
 Nov 06, 2014 BUY Strong Buy
+1729066.7% avg upside
6 analysts
$5.00
1249900.05% Upside
 · ·
ALKS
Alkermes
 Apr 03, 2009 HOLD Strong Buy
-15.2% avg upside
34 analysts
$14.00
71.49% Downside
 +39.8% ·
🔒 49 more ratings — with price targets, crowd consensus and our measured returns.
Sign in free to unlock See Pro plans
Free account unlocks every analyst's full coverage table.
Scott Henry — Frequently Asked Questions
How accurate are Scott Henry's stock ratings?
Based on the calls 13Foresight could measure, about 38% of Scott's ratings were profitable over a one-year hold, with an average return of +10.9% per rating, or +42.6% versus the S&P 500. We score every analyst the same way, from historical prices. Each return is measured in the stock's own trading currency, so for non-US listings the S&P 500 comparison leaves out currency moves.
How is Scott ranked on 13Foresight?
Scott Henry is currently ranked #1470 with a 3-star rating. Our rank blends hit rate, average return versus the market, and how many calls we have to judge — so a long, consistent record outweighs a few lucky picks. It is our own calculation, updated daily.
Which stocks does Scott cover?
Scott most recently has ratings on MDCX, VVOS, NNOX, MDWD, EVGN, IRIX, FBIO, RNXT, DERM, PTN, TNON, ICCM and 42 more. See the full coverage table above for positions, price targets and our measured returns.
Where can I see other analyst ratings?
Browse the full analyst leaderboard to compare Wall Street analysts ranked by their measured performance, success rate and average return.

Disclaimer: 13Foresight compiles analyst ratings and price targets from publicly available sources. Performance metrics, rankings and star ratings shown here are calculated independently by 13Foresight from historical market prices and may differ from figures published elsewhere. This information may be incomplete, delayed or inaccurate, is provided for research and informational purposes only, and is not investment advice. The underlying ratings and opinions are those of the respective analysts and their firms; 13Foresight accepts no liability for any decisions made based on this data.